Literature DB >> 30089270

Regulatory T Cells Promote Apelin-Mediated Sprouting Angiogenesis in Type 2 Diabetes.

Oscar M Leung1, Jiatao Li1, Xisheng Li2, Vicken W Chan2, Kevin Y Yang2, Manching Ku3, Lu Ji1, Hao Sun1, Herman Waldmann4, Xiao Yu Tian5, Yu Huang6, James Lau7, Bin Zhou8, Kathy O Lui9.   

Abstract

The role of CD4+ T cells in the ischemic tissues of T2D patients remains unclear. Here, we report that T2D patients' vascular density was negatively correlated with the number of infiltrating CD4+ T cells after ischemic injury. Th1 was the predominant subset, and Th1-derived IFN-γ and TNF-α directly impaired human angiogenesis. We then blocked CD4+ T cell infiltration into the ischemic tissues of both Leprdb/db and diet-induced obese T2D mice. Genome-wide RNA sequencing shows an increased proliferative and angiogenic capability of diabetic ECs in ischemic tissues. Moreover, wire myography shows enhanced EC function and laser Doppler imaging reveals improved post-ischemic blood reperfusion. Mechanistically, functional revascularization after CD4 coreceptor blockade was mediated by Tregs. Genetic lineage tracing via Cdh5-CreER and Apln-CreER and coculture assays further illustrate that Tregs increased vascular density and induced de novo sprouting angiogenesis in a paracrine manner. Taken together, our results reveal that Th1 impaired while Tregs promoted functional post-ischemic revascularization in obesity and diabetes.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD4 coreceptor blockade; CD4(+) regulatory T cells; apelin; type 2 diabetes; vascular function; vascular inflammation; vascular regeneration

Mesh:

Substances:

Year:  2018        PMID: 30089270     DOI: 10.1016/j.celrep.2018.07.019

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  30 in total

1.  Role of Apelin in Glioblastoma Vascularization and Invasion after Anti-VEGF Therapy: What Is the Impact on the Immune System?

Authors:  Zohreh Amoozgar; Rakesh K Jain; Dan G Duda
Journal:  Cancer Res       Date:  2019-05-01       Impact factor: 12.701

Review 2.  Reparative T lymphocytes in organ injury.

Authors:  Franco R D'Alessio; Johanna T Kurzhagen; Hamid Rabb
Journal:  J Clin Invest       Date:  2019-07-01       Impact factor: 14.808

Review 3.  Interactions between islets and regulatory immune cells in health and type 1 diabetes.

Authors:  Matthew A Budd; Mahdis Monajemi; Sarah J Colpitts; Sarah Q Crome; C Bruce Verchere; Megan K Levings
Journal:  Diabetologia       Date:  2021-09-22       Impact factor: 10.122

Review 4.  Autologous Immune Cell-Based Regenerative Therapies to Treat Vasculogenic Erectile Dysfunction: Is the Immuno-Centric Revolution Ready for the Prime Time?

Authors:  Michela Bonanni; Laura Rehak; Gianluca Massaro; Daniela Benedetto; Andrea Matteucci; Giulio Russo; Francesco Esperto; Massimo Federici; Alessandro Mauriello; Giuseppe Massimo Sangiorgi
Journal:  Biomedicines       Date:  2022-05-08

Review 5.  Tissue regulatory T cells: regulatory chameleons.

Authors:  Andrés R Muñoz-Rojas; Diane Mathis
Journal:  Nat Rev Immunol       Date:  2021-03-26       Impact factor: 53.106

6.  Single cell transcriptomic analysis identifies novel vascular smooth muscle subsets under high hydrostatic pressure.

Authors:  Zhenzhen Chen; Haizeng Zhang; Yingnan Bai; Changting Cui; Shuangyue Li; Wenjie Wang; Yue Deng; Qiannan Gao; Lu Wang; Wei Qi; Lijun Zhang; Yan Yang; Bin Geng; Jun Cai
Journal:  Sci China Life Sci       Date:  2021-01-21       Impact factor: 6.038

Review 7.  Regulatory T Cells in Angiogenesis.

Authors:  Zala Lužnik; Sonia Anchouche; Reza Dana; Jia Yin
Journal:  J Immunol       Date:  2020-11-15       Impact factor: 5.426

8.  Specific ablation of CD4+ T-cells promotes heart regeneration in juvenile mice.

Authors:  Jiatao Li; Cai Liang; Kevin Y Yang; Xiuzhen Huang; Mao Ying Han; Xisheng Li; Vicken W Chan; Kathleen S Chan; Di Liu; Zhan-Peng Huang; Bin Zhou; Kathy O Lui
Journal:  Theranostics       Date:  2020-06-29       Impact factor: 11.556

Review 9.  Beyond immune checkpoint blockade: emerging immunological strategies.

Authors:  Shawn P Kubli; Thorsten Berger; Daniel V Araujo; Lillian L Siu; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2021-03-08       Impact factor: 84.694

Review 10.  Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review).

Authors:  Alessandra Magenta; Maria Cristina Florio; Massimo Ruggeri; Sergio Furgiuele
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.